RRoche Read More Roche Stops Work on Obesity Drug Emugrobart After Trial Data2026-11-02 Roche Holding ROP -0.31%decrease; down pointing triangle said it stopped work on one of its obesity-drug candidates, after…
RRoche Read More Roche Holding Third-Quarter Sales Rise to 16.13 Billion Swiss Francs2026-10-22 Roche Holding ROP -0.56%decrease; down pointing triangle reported higher sales for the third quarter on growth in its…
RRoche Read More Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial2026-10-04 Roche ROP -1.72%decrease; down pointing triangle Holding said an obesity drug candidate met the main objectives of a…
RRoche Read More Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial2026-08-13 Roche Holding ROP 1.21%increase; up pointing triangle said a drug candidate showed better potential than existing therapies in…
RRoche Read More Roche Backs Full-Year View as First-Half Sales Rise2026-08-11 Roche Holding ROP 0.00%increase; up pointing triangle backed its full-year guidance as its pharmaceuticals division helped drive a…
RRoche Read More Roche Backs Full-Year View as Quarterly Sales Rise2026-06-12 Roche ROP 2.63%increase; up pointing triangle confirmed its full-year guidance after reporting a first-quarter rise in sales driven…
RRoche Read More Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 20302026-05-24 Roche ROP 2.42%increase; green up pointing triangle Holding expects drugs it already has on the market and a…
RRoche Read More Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools2026-05-08 Roche Holding ROP -1.01%decrease; red down pointing triangle said it agreed to buy PathAI for up to $1.05…